To determine how the R-35 antibody affects endothelial cells in non-tumor models, we stained blood vessels of various organs by using a CD31 antibody and observed no differences between the control Ab-treated and R-35 Ab-treated groups, suggesting that CD5L blocking antibodies did not affect angiogenesis in normal organs (Fig. S9D). Here, CD5L is linked to neoplasm.